# Mitochondrial Capacity Boost in ALS (MICABO-ALS) Trial

> **NCT04244630** · PHASE2 · RECRUITING · sponsor: **Dallas VA Medical Center** · enrollment: 60 (estimated)

## Conditions studied

- Amyotrophic Lateral Sclerosis (ALS)

## Interventions

- **COMBINATION_PRODUCT:** Antioxidants

## Key facts

- **NCT ID:** NCT04244630
- **Lead sponsor:** Dallas VA Medical Center
- **Sponsor class:** FED
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-11-02
- **Primary completion:** 2025-12
- **Final completion:** 2025-12
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2025-08-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04244630

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04244630, "Mitochondrial Capacity Boost in ALS (MICABO-ALS) Trial". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT04244630. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*